Clinical trial NCT03270306: Eating Behaviours, Diet and Gastrointestinal Symptoms in Children With Autism Spectrum Disorders
Official title: Eating Behaviours, Diet Quality and Gastrointestinal Symptoms in Children With Autism Spectrum Disorders and Typically Developing Children: a Case-control Study
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Autism Spectrum Disorder
Lead sponsor: Chinese University of Hong Kong
Sponsor class: OTHER
First posted: 2017-09-01
Enrollment: 130
Sex: ALL
Minimum age (years): 3
Maximum age (years): 6
Standard ages: CHILD
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Sixty five families with children of ASD of Chinese origin aged between 3 and 6 years and 65 control families with typically developing children matched by child's age (within 6 months) and sex will be recruited through invitation letters using a convenience sampling method in nurseries and kindergartens, in particular those with integrated programmes for ASD children. Some other possible channels for recruiting families with ASD children will include non-governmental organizations (NGOs) and some ASD family supporting groups.

Brief summary: This case-control study aims to compare the differences in eating behaviours, nutritional status, diet quality and gastrointestinal (GI) health between Chinese children aged 3-6 years with autism spectrum disorders (ASD) (n=65) and typically developing children (TDC) (n=65).

Detailed description: Objective: To compare the differences in eating behaviours, nutritional status, diet quality and gastrointestinal (GI) health between Chinese children aged 3-6 years with autism spectrum disorders (ASD) and typically developing children (TDC).

Hypotheses:

1. Children with ASD will show more problematic mealtime behaviours as represented by higher scores of 'limited variety' and 'food refusal' domains of the BAMBI compared to typically developing children
2. Children with ASD will have more GI symptoms, in particular constipation and diarrhea compared to typically developing children
3. Children with ASD will have a lower ratio of Bacteroidetes to Firmicutes than the typical control children
4. Children with ASD will have less desirable diet quality in terms of lower dietary index, lower dietary diversity score and lower intake of fibre, iron, calcium, zinc and vitamin C compared to typically developing children
5. A better diet quality will be associated with a more favourable gut microbial composition in children with and without ASD

Design and subjects: Case-control study including 65 families with children of ASD and 65 families with TDC matched by child's age and sex.

Outcomes: The primary outcomes will be the difference in mean scores of 'limited variety' and 'food refusal' domains of the Chinese version of BAMBI between children with ASD and typically developing children. The secondary outcomes will be the difference in the occurrence of GI symptoms in terms of constipation and diarrhea, as well as the difference in the gut microbiota profile in terms of the Bacteroidetes to Firmicutes ratio between children with ASD and typically developing children. The tertiary outcome will be the difference in the diet quality in terms of lower dietary index, lower dietary diversity score and lower intake of fibre, iron, calcium, zinc and vitamin C in children with ASD and typically developing children.

Eligibility criteria: Inclusion Criteria for Cases:

Families with their children diagnosed with ASD by paediatrician or clinical psychologist according to the standard of the fourth or fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV or DSM-V) will be included.

Exclusion Criteria for Cases:

Families will be excluded if their children have the following conditions.

* Diagnosed with chronic seizures
* Suffered from recent infection 1-month prior to data and sample collection
* With diseases or disorders that affect dietary/physical activity habits (e.g. diabetes, cystic fibrosis, cerebral palsy)
* Usage of antibiotics and antifungal medications 1-month prior to data and sample collection
* Currently participating or have recently participated (i.e. 1-month prior to data and sample collection) in any trials or dietary intervention programs
* With other major medical or psychological illness, as judged by the investigators as ineligible to participate

Inclusion Criteria for Controls:

Families with typically developing children matched by child's age (i.e. within 6 months of age) and sex will be included. Children without ASD, delays in motor and language development, as well as behaviors as reported by their parents, and those do not have first-degree relatives with ASD will be included. Parents will also be asked to complete the Chinese validated version of Social Responsiveness Scale (SRS). For children who are screened with positive results, they will be further assessed by a developmental pediatrician to ascertain the autistic status. Only those who are screened negative, or those who are screened positive but subsequently ascertained by the developmental pediatrician being free from autistic symptoms will be included.

Exclusion Criteria for Controls:

The exclusion criteria will be same as those for the families with children of ASD.

Primary outcomes:
measure: Mealtime behaviours
timeFrame: baseline
Secondary outcomes:
measure: Gastrointestinal symptoms
timeFrame: baseline
measure: Gut microbiota profile
timeFrame: baseline
Other outcomes:
measure: Current diet quality
timeFrame: baseline
measure: Usual diet quality
timeFrame: baseline
Locations:
city: Hong Kong
country: China
facility: Chinese University of Hong Kong
Study officials:
References: